Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06487533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 13 words
  2. Re-verified, no change to tracked fieldsv20
  3. Primary completion pushed from Mar 31, 2026 to Mar 31, 2027
    • Study completion pushed from May 31, 2026 to May 31, 2027
    v19
  4. Site contacts updated at 1 of 2 sites
    • Collaborators: 3 to 5
    v18
  5. 2 versions Re-verified since Sep 4, 2025, no change to tracked fieldsv16-v17
Show 14 earlier versionsHide 14 earlier versions
  1. Eligibility criteria expanded, about 3 wordsv15
  2. Primary completion date: May 2025 to Mar 31, 2026
    • Start date: Nov 21, 2024 to Feb 19, 2025
    • Study completion date: Jul 2025 to May 31, 2026
    v14
  3. 4 versions Re-verified since Dec 12, 2024, no change to tracked fieldsv10-v13
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 15, 2024 to Nov 21, 2024
    • Site details revised at 2 of 2 sites
    v9
  5. Start date: Nov 2024 to Nov 15, 2024v8
  6. Primary completion date: Mar 2025 to May 2025
    • Study completion date: May 2025 to Jul 2025
    • Start date: Oct 2024 to Nov 2024
    • Collaborators expanded, about 12 words
    v7
  7. Site contacts updated at 1 of 2 sitesv6
  8. 2 versions Re-verified since Aug 5, 2024, no change to tracked fieldsv4-v5
  9. Start date: Aug 2024 to Oct 2024
    • Primary completion date: Aug 2025 to Mar 2025
    • Study completion date: Aug 2025 to May 2025
    v3
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
Trial Details
NCT Number NCT06487533
Lead Sponsor Spark Biomedical, Inc.
Collaborators: Battelle Memorial Institute, Hazelden Betty Ford Foundation, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), The HEAL Initiative
Conditions
(from sponsor)		 Opioid Withdrawal, Opioid Use Disorder
Related terms Opioid-Related Disorders
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov